Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login
 Back To Article

  Reader Comments

Year : 2021 | Volume:  17 | Issue Number:  2

ORIGINAL ARTICLE

Ezrin is a prognostic biomarker in patients with clear cell metastatic renal cell carcinoma receiving sunitinib

Cetin Bulent, Gonul Ipek Isik, Gumusay Ozge, Afsar Baris, Bilgetekin Irem, Ozet Ahmet, Uner Aytug

Add Your Comments
 
No one has added comments on this article. Click here to add your remarks